CD19-targeted HSP90 inhibitor nanoparticle combined with TKIs reduces tumor burden and enhances T-cell immunity in murine B-cell malignancies.
CD19靶向HSP90抑制剂纳米颗粒与TKIs联合使用可降低小鼠B细胞恶性肿瘤的肿瘤负荷并增强T细胞免疫力
期刊:Theranostics
影响因子:13.3
doi:10.7150/thno.106758
Qin Mengting, Ren Juan, Chen Xiaodong, Zhou Wen, Zhang Shuyuan, Zhang Weile, Shi Mengxin, Zhang Mingzhen, Liu Huashen, Ma Yunfeng, Yang Mei, Ji Yanhong
